TUBA KAYMAN, CEYLAN POLAT, GÜL ERGÖR, YUSUF HAKAN ABACIOĞLU

Characterization of HCV genotype 4d infections in Kayseri, Turkey*

Background/aim: The frequency of genotype 4 hepatitis C virus (HCV) infections is significantly higher in Kayseri compared to other provinces in Turkey. We aimed to characterize genotype 4 infections in Kayseri by analyzing the demographic and laboratory data of 218 HCV RNA-positive, treatment-naive patients admitted to the Kayseri Training and Research Hospital in 2010 and 2011. Materials and methods: The distributions of sex, age, and viral loads of these patients with respect to HCV genotypes were analyzed. We also characterized the type 4 sequences at the subtype level. Randomly selected sera from 32 of the 72 genotype 4 patients from this cohort were subjected to PCR amplification in the NS5B region and further characterized by sequencing and phylogenetic and molecular clock analysis. Results: Distribution rates of HCV genotypes 1, 4, and 2 in the 218 patients were 62.4%, 33.0%, and 4.6%, respectively. Most of the patients infected with types 1 and 4 were over the age of 40 and female. The NS5B sequences of 32 Kayseri genotype 4 isolates were closely related with type 4d sequences but formed a separate cluster. Conclusion: The introduction of type 4d HCV into the Kayseri region probably took place 30-75 years ago, as predicted by molecular clock analysis.

Anahtar Kelimeler:

Hepatitis C virus, genotype 4d, phylogenetic analysis, Kayseri, Turkey

Characterization of HCV genotype 4d infections in Kayseri, Turkey*

Keywords:

Hepatitis C virus, genotype 4d, phylogenetic analysis, Kayseri, Turkey,

PDF

___

Shinol RC, Gale HB, Kan VL. Performance of the Abbott RealTime HCV Genotype II RUO Assay. J Clin Microbiol 2012; 50: 3099–3101.
Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, Halfon P, Inchauspé G, Kuiken C, Maertens G et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005; 42: 962–973.
Murphy D, Chamberland J, Dandavino R, Sablon E. A new genotype of hepatitis C virus originating from Central Africa. Hepatology 2007; 46: 623A.
Bostan N, Mahmood T. An overview about hepatitis C: a devastating virus. Crit Rev Microbiol 2010; 36: 91–133.
Kamal SM, Nasser IA. Hepatitis C virus genotype 4: what we know and what we don’t yet know. Hepatology 2008; 47: 1371– 1383. 6. Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol 2005; 3(10 Suppl. 2): 97–101.
Antaki N, Craxi A, Kamal S, Moucari R, Van der Merwe S, Haffar S, Gadano A, Zein N, Lai CL, Pawlotsky JM et al. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report. Liver Int 2010; 30: 342–355. 8. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245–264.
Kuiken C, Simmonds P. Nomenclature and numbering of hepatitis C virus. In: Hengli T, editor. Hepatitis C: Methods and Protocols. 2nd ed. Tallahassee, FL, USA: Florida State University; 2009. pp. 33–53.
Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107–115.
Abacioglu YH, Davidson F, Tuncer S, Yap PL, Ustacelebi S, Yulug N, Simmonds P. The distribution of hepatitis C virus genotypes in Turkish patients. J Viral Hepat 1995; 2: 297–301.
Kayman T, Karakükçü Ç, Karaman A, Gözütok F. Genotypic distribution of hepatitis C virus infection in Kayseri region. J Turk Microbiol Soc 2012; 42: 21–26 (in Turkish with English abstract).
Gökahmetoğlu S, Atalay MA, Kılınç A. Determination of the hepatitis C virus genotypes with pyrosequencing method. Erciyes Med J 2011; 33: 99–102 (in Turkish with English abstract).
Laperche S, Lunel F, Izopet J, Alain S, Dény P, Duverlie G, Gaudy C, Pawlotsky JM, Plantier JC, Pozzetto B et al. Comparison of hepatitis C virus NS5b and 5’ noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 2005; 43: 733–739.
Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005; 21: 379– 384.
Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol Biol Evol 2011; 28: 2731–2739.
Gray RR, Parker J, Lemey P, Salemi M, Katzourakis A, Pybus OG. The mode and tempo of hepatitis c virus evolution within and among hosts. BMC Evol Biol 2011; 11: 131–140.
Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. The origin of hepatitis C virus genotypes. J Gen Virol 1997; 78: 321–328.
Ciccozzi M, Ciccaglione AR, Lo Presti A, Yalcinkaya T, Taskan ZP, Equestre M, Costantino A, Bruni R, Ebranati E, Salemi M et al. Reconstruction of the evolutionary dynamics of the hepatitis C virus 1b epidemic in Turkey. Infect Genet Evol 2011; 11: 863–868.
Karaca C, Cakaloğlu Y, Demir K, Ozdil S, Kaymakoğlu S, Badur S, Okten A. Risk factors for the transmission of hepatitis C virus infection in the Turkish population. Dig Dis Sci 2006; 51: 365–369.
Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus in Europe. J Hepatol 2008; 48: 148–162.
Kahraman SÖ. Theoretical and spatial assessment of labor migration from Turkey to MENA countries. Int J Hum Sci 2012; 9: 1158–1178.
Elasifer HA, Agnnyia YM, Al-Alagi BA, Daw MA. Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients. Virol J 2010; 7: 317.
Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 1999; 58: 44–48.
Abdel-Moneim AS, Bamaga MS, Shehab GM, Abu-Elsaad AA, Farahat FM. HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate. PLoS One 2012; 7: e29781.
Altuglu I, Soyler I, Ozacar T, Erensoy S. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in Western Turkey. Int J Infect Dis 2008; 12: 239–244.
Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M, Alric L, Vinel JP, Pasquier C, Izopet J. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south- western France. J Gen Virol 2005; 86: 107–114.
Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G. Different seroprevalence and molecular epidemiology pattern of hepatitis C virus infection in Italy. J Med Virol 2005; 76: 327–332.
Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, Tsantoulas D, Vafiadi I, Hatzis G, Skoutelis A et al. Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 2006; 13: 19–27.
Fernández-Arcás N, López-Siles J, Trapero S, Ferraro A, Ibáñez A, Orihuela F, Maldonado J, Alonso A. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses. J Med Virol 2006; 78: 1429–1435.
Ciccozzi M, Equestre M, Costantino A, Marascio N, Quirino A, Lo Presti A, Cella E, Bruni R, Liberto MC, Focà A et al. Hepatitis C virus genotype 4d in Southern Italy: reconstruction of its origin and spread by a phylodynamic analysis. J Med Virol 2012; 84: 1613–1619.
Ciccozzi M, Lo Presti A, Ciccaglione AR, Zehender G, Ciotti M. Phylogeny and phylodinamic of Hepatitis C in Italy. BMC Infect Dis 2012; 12 (Suppl. 2): 5.
Chevaliez S, Bouvier-Alias M, Castera L, Pawlotsky JM. The Cobas AmpliPrep–Cobas TaqMan real-time polymerase chain reaction assay fails to detect hepatitis C virus RNA in highly viremic genotype 4 clinical samples. Hepatology 2009; 49: 1397–1398.
Vermehren J, Colucci G, Gohl P, Hamdi N, Abdelaziz AI, Karey U, Thamke D, Zitzer H, Zeuzem S, Sarrazin C. Development of a second version of the Cobas AmpliPrep/Cobas TaqMan hepatitis C virus quantitative test with improved genotype inclusivity. J Clin Microbiol 2011; 49: 3309–3315.